ECM molecules mainly induced a decrease in the viability of CLL cells of all samples (Figure 3C-i, ii) excluding FN which had prosurvival effects in LApos cases (Figure 3C-i-ii) confirming the critical role of α4 in this clinical group. The gene discussed is FN1; the disease is B-cell chronic lymphocytic leukemia.